James M. Inhofe
Former Senator · OK
Disclosed 217 stock trades between 2015 and 2021 across 90 companies.
Activity by Year
Most Traded
$206K
GE Aerospace
Aerospace and Defense
$146K
BROOKFIELD ASSET MANAGEMENT LTD
Financial Services
$132K
BlackRock Inc
Financial Services
$96K
Microsoft Corp
Technology
$145K
Citigroup Inc
Banking
$201K
Allergan (acquired by AbbVie 2020)
Healthcare
$180K
CRISPR Therapeutics AG
Biotechnology
$81K
Celgene (acquired by Bristol-Myers Squibb 2019)
Healthcare
$95K
UnitedHealth Group Incorporated
Healthcare
$165K
Sectors Traded
Trades filed after the 45-day STOCK Act deadline. The legal fine is $200 per violation.
1
late filing
Disclosed Trades
Danaher Corp
Editas Medicine Inc
Microsoft Corp
Carmax Inc
Albemarle Corp
Delta Air Lines Inc
Alibaba Group Holding Ltd
Visa Inc.
Amazon.com, Inc
Merck & Co., Inc.
Celgene (acquired by Bristol-Myers Squibb 2019)
TE Connectivity PLC
Aptiv PLC
XPO Inc
Raytheon (merged to form Raytheon Technologies/RTX 2020)
Aptiv PLC
Celgene (acquired by Bristol-Myers Squibb 2019)
American International Group Inc
GE Aerospace
Intuitive Surgical Inc
XPO Inc
Intellia Therapeutics Inc
Albemarle Corp
All data covers 2012 to end of 2025.
This is the historical record
James M. Inhofe is still trading today.
Get alerted the moment a new trade is disclosed with insider score, conflict signals, and AI-written analysis.
